These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. An immunohistochemical and genetic study of BRAF Seki-Soda M; Sano T; Ito K; Yokoo S; Oyama T Pathol Int; 2020 Apr; 70(4):224-230. PubMed ID: 31930640 [TBL] [Abstract][Full Text] [Related]
9. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology. Brunner P; Bihl M; Jundt G; Baumhoer D; Hoeller S Oral Oncol; 2015 Oct; 51(10):e77-8. PubMed ID: 26306423 [No Abstract] [Full Text] [Related]
11. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts. Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674 [TBL] [Abstract][Full Text] [Related]
12. The importance of BRAF-V600E mutation to ameloblastoma metabolism. Duarte-Andrade FF; Silva AMB; Vitório JG; Canuto GAB; Costa SFS; Diniz MG; Fernandes AP; de Toledo JS; André LC; Gomes CC; Gomez RS; Fonseca FP J Oral Pathol Med; 2019 Apr; 48(4):307-314. PubMed ID: 30739334 [TBL] [Abstract][Full Text] [Related]
13. BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice. Sant'Ana MSP; Dos Santos Costa SF; da Silva MP; Martins-Chaves RR; Pereira TDSF; de Oliveira EM; Martínez Pedraza R; de Castro WH; Gomes CC; Gomez RS; Fonseca FP J Oral Pathol Med; 2021 May; 50(5):478-484. PubMed ID: 33377543 [TBL] [Abstract][Full Text] [Related]
14. Detection and evaluation of the presence of the BRAF V600E mutation in ameloblastomas in an Indian population. Goes CF; Spadigam A; Dhupar A; Carvalho KM; Cota J; Syed S Indian J Pathol Microbiol; 2023; 66(2):246-251. PubMed ID: 37077063 [TBL] [Abstract][Full Text] [Related]
16. High frequency of BRAF V600E mutations in ameloblastoma. Kurppa KJ; Catón J; Morgan PR; Ristimäki A; Ruhin B; Kellokoski J; Elenius K; Heikinheimo K J Pathol; 2014 Apr; 232(5):492-8. PubMed ID: 24374844 [TBL] [Abstract][Full Text] [Related]
17. Discrepancy between immunohistochemistry and sequencing for BRAF V600E in odontogenic tumours: Comparative analysis of two VE1 antibodies. Oh KY; Cho SD; Yoon HJ; Lee JI; Hong SD J Oral Pathol Med; 2021 Jan; 50(1):85-91. PubMed ID: 32939809 [TBL] [Abstract][Full Text] [Related]
18. High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: Clinicopathological significance and correlation with epithelial-mesenchymal transition. Oh KY; Cho SD; Yoon HJ; Lee JI; Ahn SH; Hong SD J Oral Pathol Med; 2019 May; 48(5):413-420. PubMed ID: 30889301 [TBL] [Abstract][Full Text] [Related]
19. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours. Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Enigma of Adenoid Ameloblastoma: Literature Review Based Evidence to Consider It as a New Sub Type of Ameloblastoma. Jayasooriya PR; Abeyasinghe WAMUL; Liyanage RLPR; Uthpali GN; Tilakaratne WM Head Neck Pathol; 2022 Jun; 16(2):344-352. PubMed ID: 34282559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]